| Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia (NCT03834961) | Children's Oncology Group | 2019-10-25 |
| Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY (NCT04060849) | Fred Hutchinson Cancer Center | 2019-09-03 |
| Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting (NCT03804255) | ECOG-ACRIN Cancer Research Group | 2019-01-08 |
| Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF (NCT03604315) | M.D. Anderson Cancer Center | 2018-12-18 |
| Financial Navigation Program Intervention in Supporting Patients With Solid Tumors and Their Caregivers (NCT03775616) | Fred Hutchinson Cancer Center | 2017-11-15 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors (NCT02897375) | Emory University | 2016-10-24 |
| Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord (NCT02713269) | M.D. Anderson Cancer Center | 2016-08-29 |
| Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT02567396) | National Cancer Institute (NCI) | 2016-06-01 |
| UWCCC Molecular Tumor Board Registry (NCT03023202) | University of Wisconsin, Madison | 2016-03-30 |
| TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors (NCT02650635) | Mayo Clinic | 2016-02-05 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319) | Mayo Clinic | 2016-01-01 |
| An Investigational Device (Millar Mikro-Tip Catheter) and Imaging Scan (Shear Wave Elastography) in Measuring Tumor Pressure and Stiffness in Patients With Solid Tumors Undergoing Ultrasound-Guided Biopsy (NCT04054154) | M.D. Anderson Cancer Center | 2015-12-29 |
| Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery (NCT02540876) | University of Chicago | 2015-09-08 |
| Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer (NCT02517034) | City of Hope Medical Center | 2015-08-04 |
| Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases (NCT02360215) | NRG Oncology | 2015-07-01 |
| Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT02414724) | Roswell Park Cancer Institute | 2015-05-01 |
| Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer (NCT02188264) | National Cancer Institute (NCI) | 2014-08-29 |
| TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors (NCT02142803) | National Cancer Institute (NCI) | 2014-05-20 |
| Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction (NCT01907802) | National Cancer Institute (NCI) | 2013-08-23 |
| Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT01749384) | National Cancer Institute (NCI) | 2012-12-06 |
| Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors (NCT01552356) | National Cancer Institute (NCI) | 2012-03-19 |
| Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors (NCT01538095) | National Cancer Institute (NCI) | 2012-02-01 |
| Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors (NCT01017640) | National Cancer Institute (NCI) | 2009-10-01 |
| Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma (NCT00740805) | National Cancer Institute (NCI) | 2008-08-18 |
| Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia (NCT00503854) | M.D. Anderson Cancer Center | 2007-05-31 |
| Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors (NCT00085553) | National Cancer Institute (NCI) | 2004-05-20 |